Jesper Høiland
President and Chief Executive Officer
Biopharmaceutical industry
Radius Health Inc
United States of America
Biography
Jesper Høiland has served as our as President and Chief Executive Officer since July 2017. Mr. Høiland has 30 years of experience in the biopharmaceutical industry across numerous senior leadership roles, geographies and therapeutic areas. He brings extensive knowledge about the areas of endocrinology, biopharmaceuticals and women’s health as well as unique insights about US market access. Prior to joining Radius, Mr. Høiland served as President of Novo Nordisk Inc. USA overseeing approximately 5,300 employees. Under his leadership, Novo Nordisk solidified its market leadership and growth in diabetes and also drove significant growth in its hemophilia and growth hormone franchises. Since joining Novo Nordisk in 1987, Mr. Høiland held multiple global roles of increasing responsibility, including leading its International Operations which spanned 150 countries. Mr. Høiland is a member of the board of directors of LEO Pharma. Mr. Høiland received his M.Sc. in Management from Copenhagen Business School in Denmark.
Research Interest
Pharmacy and Business Development
